Athenesia Faggins

Athenesia Faggins, Ph.D. has a diverse work experience in the field of analytical development and material risk control strategies. Athenesia currently serves as the Director of Analytical Development at WuXi Advanced Therapies since 2022. In this role, they manage the material introduction team and processes, provides guidance to various departments, and collaborates with cross-functional teams to ensure project timelines are met. Prior to this, they worked as an Associate Director and Associate Principal Scientist at the same company, where they contributed to the development and implementation of material risk control strategies and provided support to sales, business development, and regulatory affairs teams.

Before joining WuXi Advanced Therapies, Athenesia worked at Janssen Diagnostics as a Project Manager/Independent Consultant and Scientist IV. In these roles, they successfully managed the technology transfer of hybridoma cell lines and contributed to the production campaigns of antibody-producing hybridoma cell lines. Athenesia also conducted feasibility studies and validation for new QC testing methods.

Athenesia's earlier work experience includes serving as a Graduate Researcher, GK-12 Fellow, and Graduate Teaching Assistant at Temple University. Athenesia was also a Manufacturing Scientist at Immunicon Corporation, where they performed mammalian cell culture and contributed to the formulation and packaging of reagents.

Athenesia began their career as an Undergraduate Research Assistant at Penn State University.

Overall, Athenesia Faggins, Ph.D. has demonstrated expertise in analytical development, material risk control strategies, and project management throughout their work experience.

Athenesia Faggins, Ph.D. earned their Bachelor of Science (B.S.) degree in Molecular Biology/Life Science from Penn State University, where they studied from 1998 to 2006. Athenesia then pursued further education at Temple University, where they obtained their Doctor of Philosophy (Ph.D.) degree in Biology, specializing in a field of study that was not specified, from 2007 to 2013.